Beam Therapeutics, Inc. (BEAM)
28.34
-1.42
(-4.77%)
USD |
NASDAQ |
Aug 24, 16:00
28.46
+0.12
(+0.42%)
After-Hours: 20:00
Beam Therapeutics Total Assets (Quarterly) : 1.386B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.386B |
| March 31, 2026 | 1.481B |
| December 31, 2025 | 1.481B |
| September 30, 2025 | 1.311B |
| June 30, 2025 | 1.391B |
| March 31, 2025 | 1.467B |
| December 31, 2024 | 1.104B |
| September 30, 2024 | 1.171B |
| June 30, 2024 | 1.261B |
| March 31, 2024 | 1.360B |
| December 31, 2023 | 1.460B |
| September 30, 2023 | 1.291B |
| June 30, 2023 | 1.354B |
| March 31, 2023 | 1.332B |
| December 31, 2022 | 1.342B |
| September 30, 2022 | 1.350B |
| Date | Value |
|---|---|
| June 30, 2022 | 1.418B |
| March 31, 2022 | 1.453B |
| December 31, 2021 | 1.474B |
| September 30, 2021 | 1.157B |
| June 30, 2021 | 893.08M |
| March 31, 2021 | 693.24M |
| December 31, 2020 | 451.68M |
| September 30, 2020 | 278.27M |
| June 30, 2020 | 299.98M |
| March 31, 2020 | 322.64M |
| December 31, 2019 | 156.10M |
| September 30, 2019 | 170.55M |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 167.01M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Twist Bioscience Corp. | 672.44M |
| Prime Medicine, Inc. | 249.04M |
| Intellia Therapeutics, Inc. | 857.16M |
| Sana Biotechnology, Inc. | 431.52M |
| Cartesian Therapeutics, Inc. | 318.63M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 318.91M |
| Shareholders Equity (Quarterly) | 1.067B |
| Debt to Equity Ratio | 0.2317 |
| Current Ratio | 14.57 |
| Net Debt Paydown Yield | -0.50% |